NALTREXONE HYDROCHLORIDE — all Canadian products
6 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NALTREXONE HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02444275 | APO-NALTREXONE | APOTEX INC | Tablet | Oral | NALTREXONE HYDROCHLORIDE 50 MG | Marketed | |
| 02472945 | CONTRAVE | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | Oral | NALTREXONE HYDROCHLORIDE 8 MG; BUPROPION HYDROCHLORIDE 90 MG | Marketed | |
| 02451883 | NALTREXONE HYDROCHLORIDE TABLETS USP | STERINOVA INC. | Tablet | Oral | NALTREXONE HYDROCHLORIDE 50 MG | Marketed | |
| 02213826 | REVIA | TEVA CANADA LIMITED | Tablet | Oral | NALTREXONE HYDROCHLORIDE 50 MG | Marketed | |
| 02558343 | RPC-NALTREXONE | RUSAN PHARMA CANADA INC. | Tablet | Oral | NALTREXONE HYDROCHLORIDE 50 MG | Approved | |
| 02158655 | REVIA - TAB 50MG | DUPONT MERCK PHARMA INC. | Tablet | Oral | NALTREXONE HYDROCHLORIDE 50 MG | Cancelled Post Market |
Browse other molecules: